Diagnostic utility of cortical excitability studies in amyotrophic lateral sclerosis

European Journal of Neurology

Volumn 21, Issue 12, 2014, Pages 1451-1457

  Geevasinga, N ^a   Menon, P ^a   Yiannikas, C ^b   Kiernan, M C ^c   Vucic, S ^a  

^a University of Sydney   (Australia)

^b Department of Microbiology and Infectious Diseases   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

MND; Amyotrophic lateral sclerosis; Awaji criteria; Cortical dysfunction

Indexed keywords

RILUZOLE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORTICAL EXCITABILITY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE DURATION; ELECTRODE; ELECTROMYOGRAPHY; EVOKED MUSCLE RESPONSE; EXCITABILITY; FACILITATION; FEMALE; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTONEURON; NERVE CONDUCTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRANSCRANIAL MAGNETIC STIMULATION; BRAIN CORTEX; CLASSIFICATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

AMYOTROPHIC LATERAL SCLEROSIS; CEREBRAL CORTEX; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; MALE; MIDDLE AGED; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84916196426     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12422     Document Type: Article

References (29)

1. Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet 2011; 377: 942-955.
2. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-299.
3. Chio A. ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis. J Neurol 1999; 246(Suppl. 3): 1-5.
4. de Carvalho M, Dengler R, Eisen A, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 2008; 119: 497-503.
5. Douglass CP, Kandler RH, Shaw PJ, McDermott CJ. An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease. J Neurol Neurosurg Psychiatry 2010; 81: 646-649.
6. de Carvalho M, Swash M. Awaji diagnostic algorithm increases sensitivity of El Escorial criteria for ALS diagnosis. Amyotroph Lateral Scler 2009; 10: 53-57.
7. Boekestein WA, Kleine BU, Hageman G, Schelhaas HJ, Zwarts MJ. Sensitivity and specificity of the 'Awaji' electrodiagnostic criteria for amyotrophic lateral sclerosis: retrospective comparison of the Awaji and revised El Escorial criteria for ALS. Amyotroph Lateral Scler 2010; 11: 497-501.
8. Schrooten M, Smetcoren C, Robberecht W, Van Damme P. Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: a prospective study. Ann Neurol 2011; 70: 79-83.
9. Costa J, Swash M, de Carvalho M. Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: a systematic review. Arch Neurol 2012; 69: 1410-1416.
10. Okita T, Nodera H, Shibuta Y, et al. Can Awaji ALS criteria provide earlier diagnosis than the revised El Escorial criteria? J Neurol Sci 2011; 302: 29-32.
11. Chen A, Weimer L, Brannagan T 3rd, et al. Experience with the Awaji Island modifications to the ALS diagnostic criteria. Muscle Nerve 2010; 42: 831-832.
12. Vucic S, Kiernan MC. Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2007; 78: 849-852.
13. Vucic S, Ziemann U, Eisen A, Hallett M, Kiernan MC. Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights. J Neurol Neurosurg Psychiatry 2013; 84: 1161-1170.
14. Vucic S, Howells J, Trevillion L, Kiernan MC. Assessment of cortical excitability using threshold tracking techniques. Muscle Nerve 2006; 33: 477-486.
15. Vucic S, Cheah BC, Yiannikas C, Kiernan MC. Cortical excitability distinguishes ALS from mimic disorders. Clin Neurophysiol 2011; 122: 1860-1866.
16. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999; 169: 13-21.
17. O'Brien MD. Aid to the Examination of the Peripheral Nervous System. London: W.B. Saunders, 2004: 1-3.
18. 11C](R)-PK11195 positron emission tomography study. Neurobiol Dis 2004; 15: 601-609.
19. de Carvalho M, Swash M. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve 2000; 23: 344-352.
20. Noto YI, Misawa S, Kanai K, et al. Awaji ALS criteria increase the diagnostic sensitivity in patients with bulbar onset. Clin Neurophysiol 2012; 123: 382-385.
21. Mills KR. The natural history of central motor abnormalities in amyotrophic lateral sclerosis. Brain 2003; 126: 2558-2566.
22. Mills K. Magnetic stimulation and central conduction time. In: Eisen A, ed. Clinical Neurophysiology of Motor Neuron Diseases Handbook of Clinical Neurophysiology. Amsterdam: Elsevier B.V., 2004: 283-293.
23. Vucic S, Kiernan MC. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain 2006; 129: 2436-2446.
24. Vucic S, Nicholson GA, Kiernan MC. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain 2008; 131: 1540-1550.
25. Vucic S, Cheah BC, Yiannikas C, Vincent A, Kiernan MC. Corticomotoneuronal function and hyperexcitability in acquired neuromyotonia. Brain 2010; 133: 2727-2733.
26. Vucic S, Kiernan MC. Cortical excitability testing distinguishes Kennedy's disease from amyotrophic lateral sclerosis. Clin Neurophysiol 2008; 119: 1088-1096.
27. Nihei K, McKee AC, Kowall NW. Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients. Acta Neuropathol 1993; 86: 55-64.
28. Vucic S, Lin CS-Y, Cheah BC, et al. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis. Brain 2013; 136: 1361-1370.
29. Higashihara M, Sonoo M, Imafuku I, et al. Fasciculation potentials in amyotrophic lateral sclerosis and the diagnostic yield of the Awaji algorithm. Muscle Nerve 2012; 45: 175-182.